Chordate Medical Holding AB (publ) (CMH.ST)
SEK 5.32
(8.65%)
SEK 5.32
(8.65%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.77 Million SEK | 29.65% |
| 2022 | 1.36 Million SEK | 16.49% |
| 2021 | 1.17 Million SEK | 60.64% |
| 2020 | 729.9 Thousand SEK | -57.75% |
| 2019 | 1.72 Million SEK | -51.7% |
| 2018 | 3.57 Million SEK | -7.34% |
| 2017 | 3.86 Million SEK | -5.28% |
| 2016 | 4.07 Million SEK | 132.22% |
| 2015 | 1.75 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.94 Million SEK | 9.71% |
| 2024 Q2 | 1.85 Million SEK | -4.49% |
| 2023 Q1 | 1.71 Million SEK | 25.81% |
| 2023 Q2 | 1.73 Million SEK | 0.88% |
| 2023 Q3 | 1.74 Million SEK | 0.49% |
| 2023 FY | 1.77 Million SEK | 29.65% |
| 2023 Q4 | 1.77 Million SEK | 1.66% |
| 2022 Q3 | 1.15 Million SEK | 4.37% |
| 2022 FY | 1.36 Million SEK | 16.49% |
| 2022 Q1 | 1.13 Million SEK | -3.41% |
| 2022 Q2 | 1.1 Million SEK | -2.69% |
| 2022 Q4 | 1.36 Million SEK | 18.75% |
| 2021 FY | 1.17 Million SEK | 60.64% |
| 2021 Q4 | 1.17 Million SEK | 10.71% |
| 2021 Q3 | 1.05 Million SEK | 18.92% |
| 2021 Q2 | 890.55 Thousand SEK | 23.21% |
| 2021 Q1 | 722.77 Thousand SEK | -0.98% |
| 2020 Q2 | 1.64 Million SEK | 1.39% |
| 2020 FY | 729.9 Thousand SEK | -57.75% |
| 2020 Q3 | 1.63 Million SEK | -0.73% |
| 2020 Q4 | 729.9 Thousand SEK | -55.32% |
| 2020 Q1 | 1.62 Million SEK | -6.04% |
| 2019 Q4 | 1.72 Million SEK | -43.36% |
| 2019 Q1 | 3.48 Million SEK | -2.55% |
| 2019 FY | 1.72 Million SEK | -51.7% |
| 2019 Q2 | 3.24 Million SEK | -6.9% |
| 2019 Q3 | 3.05 Million SEK | -6.02% |
| 2018 Q1 | 3.8 Million SEK | -1.51% |
| 2018 FY | 3.57 Million SEK | -7.34% |
| 2018 Q4 | 3.57 Million SEK | -9.43% |
| 2018 Q3 | 3.94 Million SEK | 11.54% |
| 2018 Q2 | 3.54 Million SEK | -6.87% |
| 2017 Q2 | 4.36 Million SEK | -3.24% |
| 2017 FY | 3.86 Million SEK | -5.28% |
| 2017 Q3 | 3.8 Million SEK | -12.88% |
| 2017 Q1 | 4.51 Million SEK | 10.8% |
| 2017 Q4 | 3.86 Million SEK | 1.42% |
| 2016 FY | 4.07 Million SEK | 132.22% |
| 2016 Q4 | 4.07 Million SEK | 0.0% |
| 2016 Q1 | - SEK | 0.0% |
| 2015 FY | 1.75 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | 74.106% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 98.539% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 98.539% |
| Arcoma AB | 28.02 Million SEK | 93.681% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | 94.026% |
| BICO Group AB (publ) | 493.1 Million SEK | 99.641% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | 97.162% |
| CellaVision AB (publ) | 126.03 Million SEK | 98.595% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | 71.04% |
| C-Rad AB (publ) | 64.09 Million SEK | 97.237% |
| Duearity AB (publ) | 4.15 Million SEK | 57.42% |
| Dignitana AB (publ) | 7.41 Million SEK | 76.111% |
| Episurf Medical AB (publ) | 3.7 Million SEK | 52.137% |
| Getinge AB (publ) | 6.41 Billion SEK | 99.972% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 205.201% |
| Iconovo AB (publ) | -4.86 Million SEK | 136.424% |
| Integrum AB (publ) | 22.36 Million SEK | 92.081% |
| Luxbright AB (publ) | 8000.00 SEK | -22036.513% |
| Mentice AB (publ) | 14.1 Million SEK | 87.444% |
| OssDsign AB (publ) | 4.3 Million SEK | 58.854% |
| Paxman AB (publ) | 19.99 Million SEK | 91.145% |
| Promimic AB (publ) | 330 Thousand SEK | -436.643% |
| Qlife Holding AB (publ) | 7.29 Million SEK | 75.714% |
| SciBase Holding AB (publ) | 11.91 Million SEK | 85.142% |
| ScandiDos AB (publ) | 22.69 Million SEK | 92.195% |
| Sectra AB (publ) | 36.59 Million SEK | 95.16% |
| Sedana Medical AB (publ) | 42.97 Million SEK | 95.879% |
| Senzime AB (publ) | 20.34 Million SEK | 91.293% |
| SpectraCure AB (publ) | 1.00 SEK | -177092000.0% |
| Stille AB | 66.55 Million SEK | 97.339% |
| Vitrolife AB (publ) | 413 Million SEK | 99.571% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 98.749% |